Contribution of CYP2D6 to 3,4- methylenedioxymethamphetamine (MDMA) disposition in humans: use of paroxetine as a metabolic inhibitor probe

M Segura; M Farré; S Pichini; AM Peiró; PN Roset; A Ramírez; J Ortuño; R Pacifici; PG Zuccaro; J Segura; la Torre R de

Contribution of CYP2D6 to 3,4- methylenedioxymethamphetamine (MDMA) disposition in humans: use of paroxetine as a metabolic inhibitor probe

M Segura, M Farré, S Pichini, AM Peiró, PN Roset, A Ramírez, J Ortuño, R Pacifici, PG Zuccaro, J Segura, la Torre R de

Department of Pharmacology, Therapeutics and Toxicology

Research output: Contribution to journal › Article › Research

Original language	English
Pages (from-to)	649-660
Journal	Clin Pharmacokinet.
Volume	44
Issue number	6
Publication status	Published - 1 Jan 2005

Cite this

@article{38c0f2f29bbc43a8bedba2ef68c84324,

title = "Contribution of CYP2D6 to 3,4- methylenedioxymethamphetamine (MDMA) disposition in humans: use of paroxetine as a metabolic inhibitor probe",

author = "M Segura and M Farr{\'e} and S Pichini and AM Peir{\'o} and PN Roset and A Ram{\'i}rez and J Ortu{\~n}o and R Pacifici and PG Zuccaro and J Segura and de, {la Torre R}",

year = "2005",

month = jan,

day = "1",

language = "English",

volume = "44",

pages = "649--660",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis International Ltd",

number = "6",

}

TY - JOUR

T1 - Contribution of CYP2D6 to 3,4- methylenedioxymethamphetamine (MDMA) disposition in humans: use of paroxetine as a metabolic inhibitor probe

AU - Segura, M

AU - Farré, M

AU - Pichini, S

AU - Peiró, AM

AU - Roset, PN

AU - Ramírez, A

AU - Ortuño, J

AU - Pacifici, R

AU - Zuccaro, PG

AU - Segura, J

AU - de, la Torre R

PY - 2005/1/1

Y1 - 2005/1/1

M3 - Article

SN - 0312-5963

VL - 44

SP - 649

EP - 660

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 6

ER -